Carisma Therapeutics Inc. Total Liabilities
Carisma Therapeutics Inc. had Total Liabilities of $7.42 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-11-12
- 2025-09-30: Liabilities $7.42M.
- 2025-06-30: Liabilities $51.02M.
- 2025-03-31: Liabilities $52.62M.
- 2024-12-31: Liabilities $58.37M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-09-30 | $7.42M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $51.02M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $52.62M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $58.37M 10-Q · filed 2025-11-12 | |
| 2024-09-30 | $53.18M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $58.98M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $62.90M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $63.02M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $60.49M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $66.31M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $70.06M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $107.02M 10-K · filed 2024-04-01 | $30.98M 10-K · filed 2023-02-28 |
| 2022-09-30 | $34.70M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $33.80M 10-Q/A · filed 2022-08-25 | |
| 2022-03-31 | $53.04M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $69.04M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $74.66M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $191.70M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $177.14M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $132.05M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $125.58M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $103.84M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $86.21M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $141.06M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $116.93M 10-Q · filed 2019-11-12 | |
| 2018-12-31 | $67.35M 10-K · filed 2020-03-16 |